- $194.24m
- -$14.48m
- $134.48m
Brief: Rxsight Q2 Revenue USD 20.8 Million Vs. IBES Estimate USD 19.2 Million
Rxsight Inc expected to post a loss of 47 cents a share - Earnings Preview
Rxsight Inc reports results for the quarter ended in March - Earnings Summary
Brief: Rxsight, Inc. Reports First Quarter 2023 Financial Results
Brief: Rxsight sees FY revenue USD 79-84 million
Rxsight Inc expected to post a loss of 53 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Esperion Therapeutics, Office Properties Income Trust, Radius Global Infrastructure
Rxsight Inc reports results for the quarter ended in December - Earnings Summary
Brief: Rxsight, Inc. Reports Q4 And Full Year 2022 Financial Results
Brief: Rxsight Expects FY revenue USD 78-83 million
Rxsight Inc expected to post a loss of 75 cents a share - Earnings Preview
RxSight falls on pricing $50 mln equity offering
Brief: Rxsight, Inc. Announces Pricing Of Public Offering Of Common Stock
Brief: Rxsight Announces Proposed Public Offering Of Common Stock
Rxsight Inc reports results for the quarter ended in September - Earnings Summary
Brief: Rxsight Inc Reports Third Quarter 2022 Financial Results
Rxsight Inc expected to post a loss of 71 cents a share - Earnings Preview
Brief: Rxsight Inc Files For Mixed Shelf Of Up To $200 Mln
Brief: RxSight Q2 Loss Per Share $0.61